Run Zheng - Search Results

Year	Number of Results
2004	3
2006	2
2008	1
2010	1
2021	2
2022	3
2023	4
2024	2

1

Liquid-liquid Phase Separation in Viral Function.

Zhang X, Zheng R, Li Z, Ma J. Zhang X, et al. Among authors: zheng r. J Mol Biol. 2023 Aug 15;435(16):167955. doi: 10.1016/j.jmb.2023.167955. Epub 2023 Jan 13. J Mol Biol. 2023. PMID: 36642156 Review.

2

Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment.

Zheng R, Ma J. Zheng R, et al. Pharmaceutics. 2022 Oct 25;14(11):2285. doi: 10.3390/pharmaceutics14112285. Pharmaceutics. 2022. PMID: 36365103 Free PMC article. Review.

3

HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy.

Wen Y, Ye S, Li Z, Zhang X, Liu C, Wu Y, Zheng R, Xu C, Tian J, Shu L, Yan Q, Ai F, Ma J. Wen Y, et al. Among authors: zheng r. Cancer Immunol Immunother. 2024 Jan 17;73(1):7. doi: 10.1007/s00262-023-03624-y. Cancer Immunol Immunother. 2024. PMID: 38231305 Free PMC article.

4

A Review of Water-Resistant Cellulose-Based Materials in Pharmaceutical and Biomedical Application.

He B, Liu X, Qi S, Zheng R, Chang M, Lin Q, Ren J. He B, et al. Among authors: zheng r. Curr Med Chem. 2021;28(40):8296-8318. doi: 10.2174/0929867328666210208113354. Curr Med Chem. 2021. PMID: 33557729 Review.

5

Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression.

Li Z, Zhang X, Liu C, Peng Q, Wu Y, Wen Y, Zheng R, Yan Q, Ma J. Li Z, et al. Among authors: zheng r. J Innate Immun. 2022;14(4):380-392. doi: 10.1159/000519363. Epub 2021 Nov 1. J Innate Immun. 2022. PMID: 34724662 Free PMC article.

6

Deficiency of Lactoferrin aggravates lipopolysaccharide-induced acute inflammation via recruitment macrophage in mice.

Liu C, Peng Q, Wei L, Li Z, Zhang X, Wu Y, Wang J, Zheng X, Wen Y, Zheng R, Yan Q, Ye Q, Ma J. Liu C, et al. Among authors: zheng r. Biometals. 2023 Jun;36(3):549-562. doi: 10.1007/s10534-022-00398-1. Epub 2022 Jun 1. Biometals. 2023. PMID: 35650365 Free PMC article.

7

Epstein-Barr virus microRNA miR-BART2-5p accelerates nasopharyngeal carcinoma metastasis by suppressing RNase Ⅲ endonuclease DICER1.

Wu Y, Zhang X, Liu C, Li Z, Wen Y, Zheng R, Xu C, Tian J, Wei L, Wang J, Yan Q, Zheng X, Ma J. Wu Y, et al. Among authors: zheng r. J Biol Chem. 2023 Sep;299(9):105082. doi: 10.1016/j.jbc.2023.105082. Epub 2023 Jul 24. J Biol Chem. 2023. PMID: 37495108 Free PMC article.

8

Epstein-Barr virus suppresses N⁶-methyladenosine modification of TLR9 to promote immune evasion.

Zhang X, Li Z, Peng Q, Liu C, Wu Y, Wen Y, Zheng R, Xu C, Tian J, Zheng X, Yan Q, Wang J, Ma J. Zhang X, et al. Among authors: zheng r. J Biol Chem. 2024 Mar 25;300(5):107226. doi: 10.1016/j.jbc.2024.107226. Online ahead of print. J Biol Chem. 2024. PMID: 38537697 Free article.

9

High-fat diet alters immune cells in spleen, kidney and tumor and impacts the volume growth of renal cell carcinoma.

Run Zheng Z, Ma K, Yue Li H, Meng Y. Run Zheng Z, et al. Int Immunopharmacol. 2023 Nov;124(Pt B):110982. doi: 10.1016/j.intimp.2023.110982. Epub 2023 Oct 18. Int Immunopharmacol. 2023. PMID: 37862740

10

Novel blood biomarkers of human urinary bladder cancer.

Osman I, Bajorin DF, Sun TT, Zhong H, Douglas D, Scattergood J, Zheng R, Han M, Marshall KW, Liew CC. Osman I, et al. Among authors: zheng r. Clin Cancer Res. 2006 Jun 1;12(11 Pt 1):3374-80. doi: 10.1158/1078-0432.CCR-05-2081. Clin Cancer Res. 2006. PMID: 16740760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year